Summary of Henry Schein FY Conference Call (March 10, 2026) Company Overview - **Company**: Henry Schein (NasdaqGS:HSIC) - **Industry**: Dental distribution and healthcare products Key Highlights from Q4 2025 - **Dental Business Growth**: Notable improvement in dental distribution growth in both the U.S. and international markets, indicating market share gains [4][5] - **Equipment Sales**: U.S. dental equipment sales exceeded 10% growth in Q4, significantly outpacing market trends, reflecting customer confidence in practice investments [5][6] - **Market Share**: Successful promotional programs contributed to growth, with a focus on new customer acquisition [5][14] Financial Guidance for 2026 - **Earnings Per Share (EPS)**: Guidance set at $5.23-$5.37, representing a 5%-8% growth [8] - **Cost Management**: Anticipated costs related to value creation initiatives in the first half of the year, with earnings growth expected to be more pronounced in the second half [9] Segment Performance - **Dental Specialty**: Strong growth in dental implants, particularly in Europe, with steady growth in the U.S. driven by a new value implant [7][41] - **Technology**: Henry Schein One holds approximately 50% market share in dental practice management systems, with new product launches aimed at improving operational efficiency for customers [7][8] - **Merchandise Growth**: Achieved 3%-4% growth in merchandise, attributed to promotional activities and recruitment of experienced sales representatives [36] Innovation and Market Trends - **Digital Transition**: Many dental practices have yet to fully embrace digital technologies, indicating a long runway for growth in digital equipment sales [22][29] - **Intraoral Scanners**: Price reductions in scanners are attracting more practices, facilitating further sales of digital equipment [29][31] Leadership Changes and Strategic Direction - **New CEO**: Fred Lowery appointed as CEO, succeeding Stanley Bergman, with a focus on fresh perspectives and strategic execution [53][56] - **KKR Investment**: KKR now holds a 19.9% stake in the company, providing new board members and a collaborative culture that supports value creation initiatives [57][60] Capital Deployment Strategy - **Share Buybacks**: $850 million in stock repurchases executed, indicating belief in the stock's undervaluation [66] - **M&A Activity**: Slower pace of acquisitions noted, with a focus on share repurchases as a priority for capital deployment [68] Market Outlook - **Positive Market Sentiment**: Signs of optimism in the dental market, with peers showing recovery from previous challenges [71] - **Customer Confidence**: Equipment sales results suggest a confident customer base willing to invest in their practices, positioning Henry Schein favorably for future growth [72]

Core Insights - Henry Schein One has launched the next era of Dentrix Ascend, introducing three new packages aimed at enhancing revenue and growth for dental practices and Dental Service Organizations (DSOs) [1] - The new offerings are built on an integrated platform that combines practice management, clinical workflows, imaging, and revenue cycle management, reflecting a shift from legacy systems to modern cloud platforms [1] Product Innovations - The new packages include advanced features such as Voice Notes, Image Verify, Eligibility Pro, and Digital Forms, which leverage AI to streamline operations and reduce administrative burdens [1] - Voice Notes uses generative AI to convert conversations into structured clinical records, while Image Verify assesses clinical images at capture to prevent claim denials [1] - Eligibility Pro performs real-time benefits checks, completing 191 million checks in 2025, and Digital Forms captures insurance data from images, with 22 million forms completed in 2025 [1] Package Offerings - Dentrix Ascend now offers three structured packages: Ascend Accelerate, Ascend Pro, and Ascend Essentials, each designed to cater to different organizational needs and scalability [1] - Ascend Accelerate is tailored for multi-location organizations, while Ascend Pro is for established practices seeking automation, and Ascend Essentials is aimed at new or smaller practices [1] Support and Implementation - The new era of Dentrix Ascend includes AI-powered support through Claire, providing 24/7 assistance and facilitating smooth migration for practices and DSOs [1] - This support aims to help organizations realize value quickly and manage complexity as they scale [1] Market Position - Dentrix and Dentrix Ascend currently serve over 48,000 practices in the U.S. and 90% of the top 50 DSOs, processing approximately 100 million claims annually [1] - The advancements in Dentrix Ascend strengthen its position as a leading platform for modern dental organizations [1]

Summary of Henry Schein Conference Call Company Overview - **Company**: Henry Schein - **Industry**: Healthcare distribution, specifically dental and medical supplies Key Points and Arguments Leadership Transition - Henry Schein has appointed Fred Lowery as the new CEO, marking the first leadership change since the first Bush administration, with Lowery being the fourth CEO in 94 years [2][3] - Lowery brings operational excellence and a fresh perspective, previously having a successful tenure at Thermo Fisher [3][4] Market Trends - The dental market shows signs of stabilization and potential improvement, with core dental market growth previously estimated at 2%-4% [6][7] - Henry Schein's sales growth in the fourth quarter exceeded market growth, attributed to aggressive customer relationship strategies and promotional partnerships [7][8] Equipment Sales - The equipment segment saw significant growth, driven by partnerships with manufacturers and exclusive promotions [8][12] - Growth in equipment sales is viewed as a bellwether for practitioners' confidence in investing in their practices, indicating potential expansion in dental services [12][13] Macro Economic Factors - Interest rates have some influence on equipment sales, but the correlation is not strong; access to care and unemployment rates are more critical indicators for market performance [15][16] - The company focuses on helping practices improve efficiency and patient throughput rather than solely discussing macroeconomic indicators with clients [16] Role of Dental Service Organizations (DSOs) - DSOs are crucial for both merchandise and equipment sales, with 25 of the 27 largest DSOs in the U.S. considering Henry Schein their primary distributor [19] - The growth of DSOs is outpacing the rest of the market, providing Henry Schein with opportunities to capture market share [19] Specialty Segment Growth - Henry Schein is positioned as a leading player in the implant and endodontic markets, with steady growth in these segments [28][30] - The company aims to expand its market share in implants, particularly through value implants that appeal to general practitioners [29][35] Technology and AI Integration - Henry Schein One is leveraging AI through a partnership with AWS to enhance its digital imaging and practice management solutions [37][38] - New products like Voice Notes and Image Verify aim to reduce administrative burdens and improve operational efficiency for practitioners [38][39] Value Creation Plan - The company is focused on a value creation plan expected to deliver $125 million in operating income improvement by the end of 2026 [47][48] - This plan emphasizes structural changes and resource optimization across the organization, differing from past grassroots restructuring efforts [52] Medical Business Expansion - Henry Schein is expanding its medical business, particularly in home healthcare, which is growing faster and more profitably than its core medical business [56] - The company is focusing on consumable merchandise rather than durable medical equipment (DME) for its Home Solutions business [58] Additional Important Insights - The company is committed to maintaining strategic relationships with DSOs to avoid transactional dynamics and focus on driving profitability for practices [23][24] - The specialty segment, particularly implants, is seen as a significant growth area, with a goal of increasing the contribution of high-margin products to over 50% of operating income by 2027 [34][35]

Financial Data and Key Metrics Changes - Global sales for Q4 2025 reached $3.4 billion, reflecting a sales growth of 7.7% compared to Q4 2024, with constant currency sales growth of 5.8% and a 1.9% increase from foreign currency exchange [28][29] - GAAP operating margin for Q4 2025 was 4.76%, a decrease of 10 basis points from the prior year, while non-GAAP operating margin was 7.42%, relatively flat compared to the prior year [29] - Q4 2025 GAAP net income was $101 million or $0.85 per diluted share, compared to $94 million or $0.74 per diluted share in the prior year [30] - Non-GAAP net income for Q4 2025 was $160 million or $1.34 per diluted share, compared to $149 million or $1.19 per diluted share in the prior year [31] Business Line Data and Key Metrics Changes - Global distribution and value-added services group sales grew by 7.0%, with U.S. dental merchandise sales increasing by 3.6% and U.S. dental equipment sales growing by 10.6% [32] - International dental merchandise sales grew by 9.2%, driven by growth across Southern and Eastern Europe, Germany, Brazil, and Canada [32] - Global specialty products group sales increased by 14.6%, with strong performance in implants and biomaterials, particularly in Germany, Brazil, and France [22][33] Market Data and Key Metrics Changes - U.S. medical distribution sales grew by 4.9%, reflecting strong growth in home solutions, while international dental equipment sales grew by 13.9% [32][33] - The U.S. dental market showed signs of stability and positive trends, with patient traffic remaining stable and a slight positive lean observed [15][51] - International equipment sales growth was broad-based, benefiting from currency exchange rates [21] Company Strategy and Development Direction - The company is executing its 2025-2027 BOLD+1 strategic plan, with non-GAAP operating income from high-growth, high-margin businesses approaching 50% of total operating income [11] - Significant progress has been made in rolling out the global e-commerce platform, henryschein.com, and partnerships with Amazon Web Services for AI integration [12][26] - The company aims to achieve over $200 million in operating income improvement through value creation initiatives, including cost savings and capturing incremental gross margin opportunities [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the stability of the U.S. dental market and the positive sentiment among dentists regarding investments in new technologies [51] - The company anticipates earnings growth to be more heavily weighted towards the second half of 2026 due to the timing of value creation initiatives [58] - Management noted that the overall market for dental implants is stable, with positive momentum in international markets, particularly in Germany [72] Other Important Information - The company repurchased approximately 2.8 million shares of common stock at an average price of $71.10 per share, totaling $200 million [35] - Operating cash flow for Q4 2025 was $381 million, compared to $204 million in Q4 2024, driven by effective working capital management [36] Q&A Session Summary Question: Guidance on operating income improvement plan - Management indicated that the benefits from the $125 million run rate will be more heavily weighted to the back half of the year, with some lumpiness expected in the quarters [41][42] Question: Growth in specialty value implants - Management noted strong growth in specialty value implants and indicated stable pricing within the market, with no unusual price increases observed [45][48] Question: Durability of market performance - Management confirmed that the U.S. dental market is stable and leaning positively, with good feelings among dentists about investing in new technologies [50][51] Question: Sustainability of implant performance - Management expressed optimism about the sustainability of implant performance, particularly in international markets, while noting that U.S. growth is more stable but less robust [67][72]

Core Insights - Henry Schein One has launched AI-driven Image Verify, enhancing its dental practice management systems [1] - This innovation is part of a series of product advancements aimed at achieving a "Clean Claims" vision in dentistry [1] - Image Verify is integrated into Dentrix and Dentrix Ascend, streamlining the claims submission process for dental practices [1]